AptaTargets (private company)

Spain
See something wrong or missing? Let us know
Offices:Madrid
Business model:B2B

AptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.71M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to AptaTargets

Name Criteria
Spain Connecta Therapeutics
73%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • At least one other investor: CDTI
  • Total raised in a similar range: 1M - 5M USD
Spain ViveBiotech
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 1M - 5M USD
Spain Naru Intelligence
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: CDTI
  • Total raised in a similar range: 1M - 5M USD
Spain InnoUp Farma
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
Spain Dietox
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 1M - 5M USD
Spain IOMED
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 1M - 5M USD
Spain Oxolife SL
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • At least one other investor: CDTI
Spain Qrem
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 1M - 5M USD
France AbolerIS Pharma
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway APIM Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Top